Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Eleven programmes financed through the second Swiss Contribution, with a total value of around CHF 221.5 million (€240 million), are now in implementation in Romania.
The Romanian Government has adopted a financing instrument worth RON 5.313 billion (€1 billion) to develop production capacities in Romania.
Enery has inaugurated the Titu solar park, a 54 MW photovoltaic plant in Dâmbovița County.
The LaDoiPași proximity store network, developed by Metro Romania, has opened 100 stores in a single day and passed the 3,000-store milestone nationwide.
Romania registered the highest annual inflation rate in the bloc for May 2026, reaching 9.7%, according to Eurostat.